Medical Director- Women's Hormone Therapy

Medical Director – Women's Health & Hormone Therapy

Medivant Healthcare is seeking a Medical Director – Women's Health & Hormone Therapy (Contractual Role) to serve as the clinical leader and external medical representative of the organization within the physician community. This position will support the development of Medivant's medical affairs infrastructure, including KOL development, Medical Advisory Board leadership, CME strategy, clinical protocol development, and governance of medical communications to ensure adherence to 503B regulatory standards. This is a contract-based engagement designed for an experienced physician leader who can provide strategic medical guidance while collaborating with Medivant's leadership and clinical teams. The role will require on-site presence approximately 4–5 times per month, along with travel to conferences and key physician engagement events as needed.

Key Responsibilities

• Develop and execute a national KOL recruitment and engagement strategy
• Identify, recruit, and manage physician leaders beginning with Wave 1 launch cities (Phoenix, Denver, Seattle, Portland, Austin)
• Build a tiered engagement model including a National Medical Advisory Board, Clinical Faculty Network, and Early Adopter prescriber community
• Establish and chair a National Medical Advisory Board (8–12 members)
• Lead quarterly advisory meetings
• Translate advisory insights into product development and strategic initiatives
• Ensure adherence to fair-market-value and compliance processes
• Partner with accredited CME providers (e.g., Medscape, ACOG, Pri-Med)
• Oversee development of educational modules on testosterone deficiency in women
• Provide clinical oversight for educational campaigns, sponsored publications, and conference materials
• Represent Medivant Healthcare at national and regional conferences including NAMS, ISSWSH, ACOG, and A4M
• Support development of symposia and KOL-led presentations
• Build and strengthen relationships within the physician community
• Develop evidence-based prescribing guidelines and patient monitoring protocols for
• Women's microdose PFS (1.25mg, 2.5mg, 5mg, 10mg weekly doses)
• Men's PFS (25mg, 50mg, 100mg)
• Provide clinical governance for nurse educator outreach programs
• Ensure communications remain within 503B compliance boundaries (factual product description and workflow education)
• Serve as clinical authority on medical communications and educational materials
• Review medical content related to training, educational materials, and physician outreach
• Ensure strict compliance with 503B promotional limitations
• Support development of investigator-initiated studies and retrospective chart reviews
• Contribute to the company's long-term clinical evidence strategy

First-Year Success Metrics

• Medical Advisory Board operational by Month 2
• 15–20 active KOL prescribers in Wave 1 cities by Month 3
• National CME module launched by Month 4
• 50+ engaged KOLs across 10+ metropolitan areas by Month 6
• Clinical protocols published and distributed
• Prescriber engagement metrics tracked by channel
• Company presence established at 3–4 major conferences

Qualifications Required

• MD or DO with an active U.S. medical license in good standing
• Clinical background in OBGYN, reproductive endocrinology, menopause medicine, sexual health, or endocrinology
• Minimum 5 years of clinical experience prescribing hormone therapy to women
• Established relationships within the women's health physician community
• Strong understanding of pharmaceutical or 503B medical affairs functions
• Familiarity with 503B compliance requirements
• Comfortable presenting at national physician conferences

Preferred

• NAMS Certified Menopause Practitioner (NCMP)
• Prior Medical Director or Medical Affairs leadership experience
• Experience developing KOL networks and advisory boards
• CME program development experience
• Published research in hormone therapy or sexual health
• Familiarity with the Biote practitioner network
• Experience managing DEA Schedule III compliance frameworks

Engagement Structure

• Contractual / consulting engagement
• On-site presence required approximately 4–5 times per month
• Travel required for conferences, advisory board meetings, and physician engagement initiatives

About The Opportunity This engagement offers the opportunity to contribute to the development of a new therapeutic category in women's health, while collaborating closely with Medivant's leadership team to build a strong clinical foundation for product adoption and medical education.